Abstract
In this issue of Blood, Iacovelli et al provide the first in vivo experimental evidence on the proleukemogenic relevance of autonomous (exo-antigen-independent) B-cell receptor (BCR) stimulation in conjunction with ligand (autoantigen)-mediated BCR signaling in chronic lymphocytic leukemia (CLL).1
Cite
CITATION STYLE
APA
Herling, M., & Vasyutina, E. (2015, March 5). Multilevel BCR signals toward CLL. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2015-01-621227
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free